JPS5925311A - Cosmetic - Google Patents

Cosmetic

Info

Publication number
JPS5925311A
JPS5925311A JP13279882A JP13279882A JPS5925311A JP S5925311 A JPS5925311 A JP S5925311A JP 13279882 A JP13279882 A JP 13279882A JP 13279882 A JP13279882 A JP 13279882A JP S5925311 A JPS5925311 A JP S5925311A
Authority
JP
Japan
Prior art keywords
skin
chondroitin sulfate
comparative example
hyaluronic acid
cosmetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP13279882A
Other languages
Japanese (ja)
Other versions
JPH0420883B2 (en
Inventor
Tatsuya Ozawa
尾沢 達也
Makoto Uzuka
宇塚 誠
Tsuneo Takayabu
恒雄 高藪
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shiseido Co Ltd
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiseido Co Ltd filed Critical Shiseido Co Ltd
Priority to JP13279882A priority Critical patent/JPS5925311A/en
Publication of JPS5925311A publication Critical patent/JPS5925311A/en
Publication of JPH0420883B2 publication Critical patent/JPH0420883B2/ja
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/007Preparations for dry skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63Steroids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/735Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

PURPOSE:To obtain a cosmetic giving moistness to the skin, improving the physiological functions of the skin, and ameliorating the emollience, springiness and surface state of the skin, by combining glycosaminoglycane with estrogen which is a feminine hormone. CONSTITUTION:The objective cosmetic contains (A) one or more glycosamino- glycane (exhibiting rapid activity when applied to the skin) selected from hyaluronic acid, chondroitin sulfate A, chondroitin sulfate B, chondroitin sulfate C, chitin, etc. or their salts and (B) estrogen (which increase the amount of hyaluronic acid). EFFECT:The activity of the component is not additive but synergistic.

Description

【発明の詳細な説明】 本発明は、グリコサミノグリカンと、エストロゲ/とを
配合することにより皮膚にうるおいを与え、皮1i+7
の生理機能を向上させて皮膚の柔軟性、・弾JJ性及び
表面状態を著るしく改善する化粧料に関するものである
DETAILED DESCRIPTION OF THE INVENTION The present invention provides moisture to the skin by blending glycosaminoglycan and estrogen,
The present invention relates to cosmetics that significantly improve the flexibility, elasticity, and surface condition of the skin by improving the physiological functions of the skin.

皮1+If医学的見地からみた場合、皮膚の老化現象は
、皮膚中のグリコサミノグリカンの減少に起因すると考
えられている。その結果、皮膚組織は柔−1ツ;性、弾
力性を失い、皮膚のシワが増大し、皮膚9[観的におと
ろえをみせる。グリコサミノグリカン、とくにそのうち
の一つであるヒアルロン酸は、士ル水効ll!:を有し
ているので、皮膚保湿の機構を考察するにあたっても極
めて重要な因子であるくフレグランスジャーナル(FR
AGRAN(I JOURN/lL )第14号第43
〜54頁1975年)。
Skin 1+If From a medical point of view, the phenomenon of skin aging is believed to be due to a decrease in glycosaminoglycans in the skin. As a result, the skin tissue loses its softness and elasticity, the wrinkles of the skin increase, and the skin 9 [visually deteriorates]. Glycosaminoglycans, especially one of them, hyaluronic acid, are extremely effective! : Therefore, it is an extremely important factor when considering the mechanism of skin moisturization. Fragrance Journal (FR)
AGRAN (I JOURN/lL) No. 14 No. 43
~54 pages 1975).

皮膚の老化現象を防止するために・あるいは若返りを計
るためにグリコサミノグリカン、例えばコンドロイチン
硫酸、ヒアルロン酸、ムコイチン硫酸、カロニン硫酸、
又はその塩類等を配合した化粧料(特公昭33−500
号公報)、あるいはヒアルロン酸およびその塩類を含有
せしめることにより、皮膚上に皮膚を保護する膜を形成
し、皮1Mをなめらかとなし、皮膚に適度の潤いとはり
をりえる乳化組成物(特開昭55−160712号公報
)等、のするものであり、皮膚上の成分は洗顔や汗など
により簡琳に洗い流されてしまうことを考えると、必ら
ずしも十分な老化防止効果を発揮するとは言い難いもの
である。
Glycosaminoglycans, such as chondroitin sulfate, hyaluronic acid, mucoitin sulfate, caronine sulfate, to prevent skin aging or to rejuvenate the skin.
or cosmetics containing its salts (Special Publication No. 33-500)
Or an emulsified composition (especially) that contains hyaluronic acid and its salts to form a protective film on the skin, make the skin smooth, and provide appropriate moisture and firmness to the skin. Considering that the ingredients on the skin are easily washed away by face washing and sweat, they do not necessarily have sufficient anti-aging effects. It is difficult to say that it will.

かかる状況にかんがみ、本発明者らは、rliに皮す 膚に不足しているグリコサミノグリカンを外面的に与え
るだけでなく皮膚の内部に働らきかけるな11ボルモン
と同時にり・えたならばより効果的ではtzいがと考え
、各種試作、試験を行った結果、グリ′−1サミノグリ
カンと父性ホルモンを配合した化il科はそれぞれを単
独に配合した化粧料に比べて、m lr的な効果を有す
ることを見い出し、本発明を完成するに至−)たのであ
る。
In view of this situation, the present inventors proposed that it would be possible to not only provide RLI externally with glycosaminoglycans that are lacking in the skin, but also to simultaneously add 11-bolone that acts on the inside of the skin. We thought that it would be more effective, and as a result of making various prototypes and testing, we found that a cosmetic that contains glyc'-1 saminoglycan and paternal hormone has a higher mlr-like effect than a cosmetic that contains each of them alone. They discovered that this method has an effect, and completed the present invention.

1!IIち、イぐ発明はグリコサミノグリカンと女性ホ
ルモ/であるエストロゲ8樽ト配合することを特徴とす
る化粧料を提供するものである◇ つまり、本発明らは皮膚上へ途布することにより速効性
を発揮するグリコサミノグリカンと皮膚組織中の真皮結
合組織に働らきかけ、ヒアルロン接菌な補給と皮LM内
部からのヒアルロン酸の補給をIllっだものであるが
、効果テストを行った結果、栄に相和的な効果でなく相
乗的な効果が得られることを見い出して、本発明に至っ
たのである。
1! II. The present invention provides a cosmetic product characterized by a combination of glycosaminoglycan and estrogen, which is a female hormone. It acts on glycosaminoglycans that exhibit fast-acting effects and the dermal connective tissue in the skin tissue, and provides hyaluronic inoculation replenishment and hyaluronic acid replenishment from within the skin's LM, but its effectiveness has been tested. As a result, they discovered that Sakae has a synergistic rather than a mutualistic effect, leading to the present invention.

(以下余白) 以下、本発明の構成について詳述する。(Margin below) Hereinafter, the configuration of the present invention will be explained in detail.

本発明で用いるグリコサミノグリカンは、例えばヒアル
ロン酸、コンドロイチン硫ll!l′A1コンドロイチ
ン硫酸B1コンドロイチン硫酸C1キチン等またはその
塩類であり、これらのうちから一種又は二種以上が任意
に選択される。
Glycosaminoglycans used in the present invention include, for example, hyaluronic acid, chondroitin sulfate! l'A1 chondroitin sulfate B1 chondroitin sulfate C1 chitin, etc., or salts thereof, and one or more types are arbitrarily selected from these.

グリコサミノグリカンの塩を形成する塩基としニン等の
塩基性アミノ酸等を例示することができるO グリコサミノグリカン及び/又はその塩の配合量は該化
粧料に対して005重N%以上が好ましい。
Examples include basic amino acids such as nin as a base for forming glycosaminoglycan salts. preferable.

本発明で用いるエストロゲンは、例えばエチニルエスト
ラジオール、〕〕7β−エストラジA−ルエストロン、
ニストリA−ル、ジエチルスチルベストロール、ヘキセ
ストロール等であり、こねらのうちから一種又は二種以
上が任意に選ばれ使用される。
Estrogens used in the present invention include, for example, ethinyl estradiol, 7β-estradiA-luestrone,
These include Nistral, diethylstilbestrol, hexestrol, etc., and one or more of them are arbitrarily selected and used.

配合11[は0.0001重量%以上が好ましい。Blend 11 [is preferably 0.0001% by weight or more.

以下、実施例により本発明及び本発明の効果に−)いて
1!工・述する。本発明はこれにより限定されるもので
はない。
Hereinafter, the present invention and the effects of the present invention will be explained with reference to Examples. Engineering and description. The present invention is not limited thereby.

(以下余白) 実施例14  比較例1.2 モイスチュアクリーム(
製 法) Aの油相部、お上びBの水相部をそれぞれ70°Cに加
熱し完全溶解したのち、油相部を水相部中に1111記
実施例1.比較例1.2のモイスチュアクリームを女性
パイ、ル刃名に使用させた。
(Left below) Example 14 Comparative example 1.2 Moisture cream (
Manufacturing method) The oil phase of A and the aqueous phase of B are heated to 70°C and completely dissolved, and then the oil phase is added to the aqueous phase in Example 1 of 1111. The moisture cream of Comparative Example 1.2 was used on a woman's pie, Le Haname.

01υI lit  昭和57年1月10日〜57年2
り]0日0 使用方法:顔左右半々に実施例1と比較例
1を10名(lグループ)、実施例1と比較例2を10
名(IIlグループ、比較例1と比較例2を〕0名ずつ
(■グループ)、1日lh回塗布した。
01υI lit January 10, 1980 - 2, 1982
] 0 days 0 How to use: Apply Example 1 and Comparative Example 1 to 10 people (l group), and apply Example 1 and Comparative Example 2 to 10 people on both sides of the face.
(Group II, Comparative Example 1 and Comparative Example 2) 0 people each (Group ■) applied the solution 1h times a day.

0 評価項目 1ケ月後の肌のしなやかさ、皮膚のはりを官能テストで
パネルに自己申告させて判定した。結果を表2に示す。
0 Evaluation Items Skin suppleness and skin firmness after one month were evaluated by having the panel self-report in a sensory test. The results are shown in Table 2.

(以下余白) 表2(j@ 次に実施例1、比較例1の皮膚改善効果を皮膚のコンダ
クタンスを測定することにより評価した。
(The following is a margin) Table 2 (j@ Next, the skin improvement effects of Example 1 and Comparative Example 1 were evaluated by measuring skin conductance.

jj法:高周波インピーダンスメーター(アイビイニス
株式会社製)をもちいて皮膚の保水状態をコンダクタン
ス値の測定により評価した。実施例1と比較例1を毎日
−回2週間塗布し、塗布前ト後でd(!l 定したコン
ダクタンス値のa (10人で測定し平均値で表わした
)を表3に示す。数値が大きい程、皮膚の状態が改善さ
れたことを示す。
jj method: The water retention state of the skin was evaluated by measuring the conductance value using a high frequency impedance meter (manufactured by Ibinis Co., Ltd.). Example 1 and Comparative Example 1 were applied once every day for two weeks, and the determined conductance values (a (measured by 10 people and expressed as an average value) before and after application) are shown in Table 3. Numerical values The larger the value, the better the skin condition.

表3に示した様に実施例1では塗布前に比べ皮フの保水
状態が著しく向上しているのに対し比較例1においては
、はとんどその効果はみられなかった。
As shown in Table 3, in Example 1, the water retention state of the skin was significantly improved compared to before application, whereas in Comparative Example 1, no such effect was observed.

表3  (塗布後の皮膚のコンダクタンス)−、−(塗
布前の皮膚のコンダクタンス)次いで実施例1と比較例
1の皮膚表面状態の改善効果を観察した。
Table 3 (Skin conductance after application) -, - (Skin conductance before application) Next, the effect of improving the skin surface condition of Example 1 and Comparative Example 1 was observed.

方法:皮膚の表面形態をレプリカ法(特開昭54−56
280号公報)により観察した。
Method: Replica method of skin surface morphology (Japanese Patent Application Laid-open No. 54-56
No. 280).

実施例1と比較例1を毎日−回2週間塗布し、塗布前と
塗布後の皮膚のレプリカを取り、顕微鏡写真にて撮影し
・比較観察した。
Example 1 and Comparative Example 1 were applied once every day for two weeks, and replicas of the skin before and after application were taken, micrographs were taken, and comparative observations were made.

結果を図1に示す。Aは使用前の一女性の左頬部の皮膚
表面状態であり・Bは同じ女性の右頬部のものである。
The results are shown in Figure 1. A shows the skin surface condition of the left cheek of a woman before use, and B shows the skin surface condition of the same woman's right cheek.

Cは実施例1のクリームを使用した後の左頬部の表面状
態で・Dは比較例1を使用した後の右の頬部のものであ
る・ これらから明らかな通り、使用前は両者はぼ同様の皮膚
形態であるが、2週間後の状態を観察すると実施例1で
は明らかに皮丘皮溝が明確になり本発明品はいちじるし
い改善効果があるという結果を得た。
C is the surface condition of the left cheek after using the cream of Example 1.D is the surface condition of the right cheek after using Comparative Example 1.As is clear from these, before use, both were Although the skin morphology was similar, when the condition was observed after 2 weeks, the condyles and grooves were clearly defined in Example 1, indicating that the product of the present invention had a remarkable improvement effect.

一方比較例1では皮丘、皮溝が明確にならず改善効果は
ほとんど見られない。
On the other hand, in Comparative Example 1, the skin ridges and skin grooves were not clearly defined and almost no improvement effect was observed.

実施例2 栄養乳液 (製法) への油相部、およびBの゛水相部をそれぞれ70’に加
熱し完全溶解したのち、油相部を水相部中に混合し、乳
化機にて乳化する。乳化物を熱交換器にて終l晶m′C
まで冷却したのち充填を行った。
Example 2 Nutritional emulsion (manufacturing method) After heating the oil phase to the nutritional emulsion (manufacturing method) and the aqueous phase of B to completely dissolve them, the oil phase was mixed into the aqueous phase and emulsified using an emulsifier. do. The emulsion is subjected to final crystallization m'C in a heat exchanger.
After cooling to a certain temperature, filling was performed.

クリームの実施例1と同様な効果があった。The same effect as in Example 1 of the cream was obtained.

実施例3 スキンローション (IIZ) (製 法) A部、およびB部をそれぞれ室温にて攪拌完全溶解した
のち・B部にA部を混合して可溶化し、濾過機にて濾過
した。
Example 3 Skin lotion (IIZ) (Manufacturing method) Parts A and B were stirred and completely dissolved at room temperature, and then part A was mixed with part B to solubilize it, and the mixture was filtered using a filter.

実施例1と同様な効果があった00 had the same effect as Example 1

【図面の簡単な説明】[Brief explanation of the drawing]

図1(写真)は生物(人)の形態(皮膚表面状態)を示
す。 A:塗布前の左頬部 B;塗布前の右頬部 c:’JNMM例1のモイスチュアクリーム使用後の左
頬部 D=比較例1のモイスチュアクリーム使用後の右頬部 特許出願人 株式会社 資 生堂 1
Figure 1 (photo) shows the morphology (skin surface condition) of an organism (human). A: Left cheek area before application B; Right cheek area before application c: 'Left cheek area after using the moisture cream of JNMM Example 1 D = Right cheek area after using the moisture cream of Comparative Example 1 Patent applicant Co., Ltd. Shiseido 1

Claims (1)

【特許請求の範囲】[Claims] グリコサミノグリカンと、エストロゲンとを配合するこ
とを特徴とする化粧料。
A cosmetic characterized by containing glycosaminoglycan and estrogen.
JP13279882A 1982-07-29 1982-07-29 Cosmetic Granted JPS5925311A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP13279882A JPS5925311A (en) 1982-07-29 1982-07-29 Cosmetic

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13279882A JPS5925311A (en) 1982-07-29 1982-07-29 Cosmetic

Publications (2)

Publication Number Publication Date
JPS5925311A true JPS5925311A (en) 1984-02-09
JPH0420883B2 JPH0420883B2 (en) 1992-04-07

Family

ID=15089808

Family Applications (1)

Application Number Title Priority Date Filing Date
JP13279882A Granted JPS5925311A (en) 1982-07-29 1982-07-29 Cosmetic

Country Status (1)

Country Link
JP (1) JPS5925311A (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6440412A (en) * 1987-08-06 1989-02-10 Pola Chem Ind Inc Cosmetic
US5767106A (en) * 1992-02-21 1998-06-16 Hyal Pharmaceutical Corporation Treatment of disease and conditions associated with macrophage infiltration
US5824658A (en) * 1990-09-18 1998-10-20 Hyal Pharmaceutical Corporation Topical composition containing hyaluronic acid and NSAIDS
US5910489A (en) * 1990-09-18 1999-06-08 Hyal Pharmaceutical Corporation Topical composition containing hyaluronic acid and NSAIDS
US5977088A (en) * 1991-07-03 1999-11-02 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US5990096A (en) * 1990-09-18 1999-11-23 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US6140312A (en) * 1992-02-20 2000-10-31 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US6218373B1 (en) 1992-02-20 2001-04-17 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
WO2006004759A3 (en) * 2004-06-29 2006-03-16 Stephanie N Mcclellan Topical compositions for anti-aging

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5064442A (en) * 1973-10-06 1975-05-31

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5064442A (en) * 1973-10-06 1975-05-31

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6440412A (en) * 1987-08-06 1989-02-10 Pola Chem Ind Inc Cosmetic
US5824658A (en) * 1990-09-18 1998-10-20 Hyal Pharmaceutical Corporation Topical composition containing hyaluronic acid and NSAIDS
US5910489A (en) * 1990-09-18 1999-06-08 Hyal Pharmaceutical Corporation Topical composition containing hyaluronic acid and NSAIDS
US5962433A (en) * 1990-09-18 1999-10-05 Hyal Pharmaceutical Corporation Topical composition containing hyaluronic acid and NSAIDS
US5990096A (en) * 1990-09-18 1999-11-23 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US5977088A (en) * 1991-07-03 1999-11-02 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US6140312A (en) * 1992-02-20 2000-10-31 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US6218373B1 (en) 1992-02-20 2001-04-17 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US5767106A (en) * 1992-02-21 1998-06-16 Hyal Pharmaceutical Corporation Treatment of disease and conditions associated with macrophage infiltration
WO2006004759A3 (en) * 2004-06-29 2006-03-16 Stephanie N Mcclellan Topical compositions for anti-aging
US8039012B2 (en) 2004-06-29 2011-10-18 McKA, LLC Topical compositions for anti-aging and methods of using same

Also Published As

Publication number Publication date
JPH0420883B2 (en) 1992-04-07

Similar Documents

Publication Publication Date Title
JP7083090B2 (en) Pore-specific beauty essence with EVERYCO extract added and its preparation method
JP2832119B2 (en) Cosmetics
CN109602648A (en) A kind of composition and its preparation method and application with reparation and senile-resistant efficacy
CN110123721B (en) Shampoo composition for improving oily scalp
CN107468582A (en) One kind is compacted anti-wrinkle eye shadow and preparation method thereof
CN113768809B (en) Composition with mild exfoliating effect and preparation method and application thereof
JPS5925311A (en) Cosmetic
JPS61180705A (en) Cosmetic
CN106727132A (en) A kind of gentle moisturizing mildy wash and preparation method thereof
JP2005330285A (en) Skin moisturizing cosmetic composition
CN102188359B (en) Application of leech to nursing of hair or scalp of head, composition and preparation method
CN110074996A (en) A kind of moisture saver mask and preparation method thereof with liquid crystal structure
JPS60116618A (en) Cosmetic
CN106074305B (en) A kind of Noni fruit toothpaste and preparation method thereof with oral mucosa protective effect
JP2532495B2 (en) Skin cosmetics
JP3104938B2 (en) Cosmetics
JP2008169196A (en) External preparation for skin
JPS617208A (en) Pack and peel preparation containing plant powder
JPH0466843B2 (en)
JP2015127319A (en) Skin external preparation
JP2002275027A (en) Cosmetic and cosmetic impregnated in nonwoven fabric
JPS62209009A (en) Cosmetic
JP5154283B2 (en) Topical skin preparation
CN114146005B (en) Stick-shaped skin care product for moisturizing and preparation method thereof
JPS6078910A (en) Skin cosmetic